SonoThera

Funding and NIH signals

• SEC Form D raise Raised $125.45M (Form D filed Jun 30, 2026); since then posted 2 roles. SEC Form D 0001945154-26-000002 (Jun 30, 2026)
  Evidence (1 event)

  • Jun 30, 2026 · SEC Form D 0001945154-26-000002
    Name of Issuer: SonoThera, Inc.; CIK: 1945154; Address: South San Francisco, CA; Submission type: D; Filing date: 2026-06-30; Industry Group: Biotechnology; Date of First Sale: 2026-06-08; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 125450218; Total Amount Sold: 125450218; Federal exemptions: 06c

Job counts as of Oct 18, 2026. All funding and NIH signals

Raises and deals from press releases

• Raise Series B · $125M · announced Jun 10, 2026 Company release ↗
  Source quote

  • Jun 10, 2026 · Company release ↗
    “SonoThera , a biotechnology company developing next-generation genetic medicines to address the root causes of disease, today announced the closing of an oversubscribed $125 million Series B”

Raises announced in these releases: $125M disclosed.

From the company’s own releases; this list is partial. All raises and deals